B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

Citation
Sy. Tseng et al., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells, J EXP MED, 193(7), 2001, pp. 839-845
Citations number
41
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF EXPERIMENTAL MEDICINE
ISSN journal
00221007 → ACNP
Volume
193
Issue
7
Year of publication
2001
Pages
839 - 845
Database
ISI
SICI code
0022-1007(20010402)193:7<839:BANDCM>2.0.ZU;2-1
Abstract
Dendritic cells (DCs), unique antigen-presenting cells (APCs) with potent T cell stimulatory capacity, direct the activation and differentiation of T cells by providing costimulatory signals. As such, they are critical regula tors of both natural and vaccine-induced immune responses. A new B7 family member, B7-DC, whose expression is highly restricted to DCs, was identified among a library of genes differentially expressed between DCs and activate d macrophages. B7-DC fails to bind the B7.1/2 receptors CD28 and cytotoxic T lymphocyte-associated antigen (CTLA)-4, but does bind PD-1, a receptor fo r B7-H1/PD-L1. B7-DC costimulates T cell proliferation more efficiently tha n B7.1 and induces a distinct pattern of lymphokine secretion. In particula r, B7-DC strongly costimulates interferon gamma but not interleukin (IL)-4 or IL-10 production from isolated naive T cells, These properties of B7-DC may account for some of the unique activity of DCs, such as their ability t o initiate potent T helper cell type 1 responses.